go-v.orgdoi

Coronavirus (COVID-19): does Ivermectin prevent transmission or aid in the treatment of COVID-19?

Vanessa Jordan · Journal of Primary Health Care · 2021

  • DOI 10.1071/hc19563
  • Publisher CSIRO Publishing
  • Type article
  • Issued 2021

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Primary Health Care · CSIRO Publishing · article · 2021

Abstract

BACKGROUND: On 11 March 2020 the World Health Organisation (WHO) declared the novel coronavirus (COVID-19) outbreak a global pandemic.2 As the world comes to terms with this new virus many existing treatments have been repurposed and trialled to determine efficacy and prevention against for COVID-19 infection.Ivermectin is one of these treatments.Ivermectin was discovered in the late 1970s and was the first in a list of new antiparasitic drugs.3 Following the outbreak of COVID-19 Ivermectin was shown to inhibit the replication of SARS-CoV-2 in vitro.4 Clinical studies 5 rapidly ensued but as a result of poor trial methodology and small sample sizes it has been hard to get a clear picture of the overall effect of Ivermectin on patients suffering with COVID-19.The Cochrane review reported on here, set out to determine the effect of treatment and prevention when Ivermectin is used to combat COVID-19 in randomised controlled trials.

1 CLINICAL BOTTOM LINE: This Cochrane review found that at this stage there are very few completed well conducted studies examining the effect of Ivermectin on both the prevention and treatment of COVID-19.When reporting the primary analyses there is no apparent difference between Ivermectin and standard care or placebo for the treatment or transmission of COVID-19. 1 There are currently 31 trials underway looking at Ivermectin as a possible treatment for COVID-19 1 but until the results of these are known there is currently no evidence to support its use outside of clinical trials.

Open the resolved locator · 10.1071/hc19563

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:24 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.1071/hc19563
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.